Stereotactic Transplantation of hAESCs for Parkinson's Disease
Trial
Early Phase 1
Completed
April 11, 2023
Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease
Trial
Phase 2
Terminated
April 11, 2023
Constipation and Changes in the Gut Flora in Parkinson's Disease
Trial
N/A
Unknown
April 11, 2023
iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS
Trial
N/A
Not yet recruiting
April 11, 2023
Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease
Trial
Phase 3
Completed
April 11, 2023
Azilect® In Wearing-Off (AIWO)
Trial
N/A
Completed
April 11, 2023
Aqua Stand-Up Paddle Balance Effect in Parkinson's Disease (AquaSUP PARK)
Trial
N/A
Completed
April 9, 2023
Progression in Cognitive ADLs in Parkinson's Disease
Trial
N/A
Unknown
April 9, 2023
Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease
Trial
Phase 2
Completed
April 6, 2023
Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties
Trial
N/A
Completed
April 6, 2023
Promoting BEST (BEtter, Faster, Longer, STronger) Walking for People With Parkinson's
Trial
N/A
Unknown
April 5, 2023
Programmes de Marche Active et qualité de Vie Dans la Maladie de Parkinson
Trial
N/A
Withdrawn
April 5, 2023
Rehabilitation in Parkinson Disease Cyclone in Life
Trial
N/A
Completed
April 5, 2023
Gait Training With antiGRAVIty TREadmill 'Alter-G', in Patients With ParkinSON Disease
Trial
N/A
Unknown
April 5, 2023
Molecular Characterization of Induced Neuronal Cells in Parkinson's Disease
Trial
N/A
Unknown
April 3, 2023
Fatigue, Sleep and Quality of Life in Parkinson's Patients
Trial
N/A
Completed
April 3, 2023
The Effect of Combined Speech and Music-therapy on the Speech Characteristics of People With Parkinson's Disease (PD)
Trial
N/A
Completed
April 3, 2023
Bringing Parkinson Care Back Home
Trial
N/A
Unknown
April 3, 2023
Translation of Parkinson's Disease Questionnaire -8 in Urdu Language
Trial
N/A
Completed
April 2, 2023